Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
2846.2000 -10.80 (-0.38%)
NSE Jun 06, 2025 15:31 PM
Volume: 76,490
 

2846.20
-0.38%
ICICI Securities Limited
Dr Lal PathLabs’ (Dr Lal) Q2FY25 revenue growth of 9.8% YoY was lower than our expectation, though its better EBITDA margin of 30.7% was a surprise.
Dr. Lal Pathlabs Ltd. is trading below its 200 day SMA of 2941.9
More from Dr. Lal Pathlabs Ltd.
Recommended